Technical Analysis for PETQ - PetIQ, Inc.

Grade Last Price % Change Price Change
B 41.68 6.49% 2.54
PETQ closed up 5.78 percent on Monday, April 19, 2021, on 3.6 times normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical PETQ trend table...

Date Alert Name Type % Chg
Gilligan's Island Sell Setup Bearish Swing Setup 6.49%
New 52 Week Closing High Bullish 6.49%
Expansion Breakout Bullish Swing Setup 6.49%
Pocket Pivot Bullish Swing Setup 6.49%
Volume Surge Other 6.49%
New 52 Week High Strength 6.49%
Multiple of Ten Bearish Other 6.49%
BB Squeeze Ended Range Expansion 6.49%
Above Upper BB Strength 6.49%
Gapped Up Strength 6.49%
Older End-of-Day Signals for PETQ ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High 9 minutes ago
New 52 Week High 9 minutes ago
Up 5% 9 minutes ago
Possible Pocket Pivot 44 minutes ago
60 Minute Opening Range Breakout about 2 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


PetIQ, Inc. Description

PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.


Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Retail Stores Pain Diabetes Antibiotic Thyroid Dogs Control Products Antibiotics Arthritis Retail Channel Wellness Products Zoonoses E Commerce Channels Wellness Dirofilaria Immitis Rimadyl

Is PETQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 41.15
52 Week Low 22.73
Average Volume 266,589
200-Day Moving Average 33.38
50-Day Moving Average 35.56
20-Day Moving Average 35.81
10-Day Moving Average 36.60
Average True Range 1.50
ADX 17.71
+DI 37.14
-DI 11.43
Chandelier Exit (Long, 3 ATRs ) 36.64
Chandelier Exit (Short, 3 ATRs ) 37.61
Upper Bollinger Band 38.25
Lower Bollinger Band 33.38
Percent B (%b) 1.18
BandWidth 13.59
MACD Line 0.58
MACD Signal Line 0.29
MACD Histogram 0.2936
Fundamentals Value
Market Cap 989.7 Million
Num Shares 25.3 Million
EPS 0.20
Price-to-Earnings (P/E) Ratio 200.72
Price-to-Sales 0.94
Price-to-Book 3.24
PEG Ratio 0.83
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.71
Resistance 3 (R3) 42.98 42.07 42.12
Resistance 2 (R2) 42.07 41.16 41.93 41.92
Resistance 1 (R1) 40.60 40.60 40.15 40.33 41.72
Pivot Point 39.69 39.69 39.46 39.55 39.69
Support 1 (S1) 38.22 38.78 37.77 37.95 36.56
Support 2 (S2) 37.31 38.22 37.17 36.36
Support 3 (S3) 35.84 37.31 36.17
Support 4 (S4) 35.57